▁medical ▁care ▁is ▁needed . ▁ ▁Tre at ment ▁▁ ▁In ▁many ▁cases , ▁ne on atal ▁di ab etes ▁may ▁be ▁treated ▁with ▁or al ▁sul fony l ure as ▁such ▁as ▁g ly bur ide . ▁Phys icians ▁may ▁order ▁gen etic ▁tests ▁to ▁determine ▁whether ▁or ▁not ▁transition ing ▁from ▁ins ul in ▁to ▁sul fony l ure a ▁dru gs ▁is ▁appropriate ▁for ▁a ▁patient . ▁ ▁The ▁transfer ▁from ▁ins ul in ▁in jections ▁to ▁or al ▁gli ben clam ide ▁ther apy ▁seems ▁highly ▁effective ▁for ▁most ▁patients ▁and ▁safe . ▁This ▁ill umin ates ▁how ▁the ▁mole cular ▁understanding ▁of ▁some ▁mon ogen ic ▁form ▁of ▁di ab etes ▁may ▁lead ▁to ▁an ▁unexpected ▁change ▁of ▁the ▁treatment ▁in ▁children . ▁This ▁is ▁a ▁spect ac ular ▁example ▁of ▁how ▁the ▁ph arm ac ogen omic ▁approach ▁impro ves ▁in ▁a ▁trem end ous ▁way ▁the ▁quality ▁of ▁life ▁of ▁the ▁young ▁di ab etic ▁patients . ▁ ▁Ins ul in ▁Ther apy ▁▁▁▁ ▁Long ▁Act ing ▁Ins ul in : ▁( In s ul in ▁gl arg ine )- is ▁a ▁h orm one ▁that ▁works ▁by ▁lower ing ▁levels ▁of ▁blood ▁gl uc ose . ▁It ▁starts ▁to ▁work ▁several ▁hours ▁after ▁an ▁injection ▁and ▁keeps ▁working ▁for ▁ 2 4 ▁hours . ▁It ▁is ▁used ▁to ▁manage ▁blood ▁gl uc ose ▁of ▁di abet ics . ▁It ▁is ▁used ▁to ▁treat ▁Type ▁ 1 ▁and ▁ 2 ▁di ab etes ▁in ▁adult s